Skip to content

Supplier News

Eli Lilly takes aim at diabetes

Eli Lilly and Co. this weekend is participating in an event hosted by the American Diabetes Association (ADA) to help raise awareness among African-Americans about the need to better manage diabetes. The 12th annual Victory Over Diabetes event on Aug.

Former Actavis CEO to join Watson

Sigurdur Oli Olafsson, formerly chief executive officer of Actavis Group, is joining Watson Pharmaceuticals as executive vice president of global generics. Watson said Wednesday that Olafsson will start in the position on Sept. 1.

AmerisourceBergen exec gets promoted

AmerisourceBergen Corp. has promoted Barbara Brungess to vice president of corporate and investor relations. The pharmaceutical and health care distributor said Tuesday that the move is effective immediately. Brungess succeeds Michael Kilpatric, who is retiring on Dec.

Watson promotes global operations executive

Watson Pharmaceuticals has promoted Robert Stewart to executive vice president of global operations. Watson said Tuesday that Stewart, who joined the company in November 2009 as senior vice president of global operations, will continue to report to Paul Bisaro, president and chief executive officer.

Merz cleared to market Xeomin

Merz Pharmaceuticals has received Food and Drug Administration approval for Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm.